ScholarIQanswers from OpenAlex
BRCA gene mutations in cancer
TopicLeading institutions, researchers & key papers
BRCA gene mutations in cancer is a topic indexed in ScholarIQ from OpenAlex.
What is known about BRCA gene mutations in cancer?
ScholarIQrecord summary
This cluster of papers focuses on genetic research related to BRCA1 and BRCA2 mutations, and their association with breast and ovarian cancer risk. It covers topics such as genetic testing, precision medicine, genomic medicine, and the impact of mutations on cancer susceptibility.
How many works does BRCA gene mutations in cancer have?
ScholarIQindexed works
BRCA gene mutations in cancer has 314 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for BRCA gene mutations in cancer?
ScholarIQopenalex
The OpenAlex for BRCA gene mutations in cancer is on the source record.
What are the most-cited papers on BRCA gene mutations in cancer?
ScholarIQmost cited works
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
Paul Lichtenstein, Niels V. Holm, Pia K. Verkasalo, Anastasia Iliadou, Jaakko Kaprio, Markku Koskenvuo, Eero Pukkala, Axel Skytthe, Kari Hemminki
Cancer Statistics, 2002
Ahmedin Jemal, Anish Thomas, Thomas S. Murray, Michael J. Thun
Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
Karoline Kuchenbaecker, John L. Hopper, Daniel R. Barnes, Kelly‐Anne Phillips, Thea M. Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E. van Leeuwen, Roger L. Milne, Nadine Andrieu, David E. Goldgar, Mary Beth Terry, Matti A. Rookus, Douglas F. Easton, Antonis C. Antoniou, Lesley McGuffog, D. Gareth Evans, Daniel Barrowdale, Debra Frost, Julian Adlard, Kai-Ren Ong, Louise Izatt, Marc Tischkowitz, Rosalind A. Eeles, Rosemarie Davidson, Shirley Hodgson, Steve Ellis, Catherine Noguès, Christine Lasset, Dominique Stoppa‐Lyonnet, Jean‐Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J. Hooning, Lizet E. van der Kolk, Carolien M. Kets, Muriel A. Adank, Esther M. John, Wendy K. Chung, Irene L. Andrulis, Melissa C. Southey, Mary B. Daly, Saundra S. Buys, Ana Osório, Christoph Engel, Karin Kast, Rita K. Schmutzler, Trinidad Caldés, Anna Jakubowska, Jacques Simard, Michael Friedländer, Sue‐Anne McLachlan, Eva Macháčková, Lenka Foretová, Yen Y. Tan, Christian F. Singer, Edith Oláh, Anne‐Marie Gerdes, Brita Arver, Håkan Olsson
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton, Karen A. Pooley, Alison M. Dunning, Paul D.P. Pharoah, Deborah J. Thompson, Dennis G. Ballinger, Jeffery P. Struewing, Jonathan J. Morrison, Helen I. Field, Robert Luben, Nicholas J. Wareham, Shahana Ahmed, Catherine S. Healey, Richard Bowman, The SEARCH collaborators, Craig Luccarini, Don Conroy, Mitul Shah, Hannah Munday, Clare Jordan, Barbara Perkins, Judy West, Karen Redman, Kristy Driver, Kerstin B. Meyer, Christopher A. Haiman, Laurence Kolonel, Brian E. Henderson, Loı̈c Le Marchand, Paul Brennan, Suleeporn Sangrajrang, Valérie Gaborieau, Fabrice Odefrey, Chen‐Yang Shen, Pei‐Ei Wu, Hui‐Chun Wang, Diana Eccles, D. Gareth Evans, Julian Peto, Olivia Fletcher, Nichola Johnson, Sheila Seal, Michael R. Stratton, Nazneen Rahman, Georgia Chenevix-Trench, Stig E. Bojesen, Børge G. Nordestgaard, C. K. Axelsson, Montserrat García‐Closas, Louise A. Brinton, Stephen J. Chanock, Jolanta Lissowska, Beata Pepłońska, Heli Nevanlinna, Rainer Fagerholm, Hannaleena Eerola, Daehee Kang, Keun-Young Yoo, Dong‐Young Noh, Sei Hyun Ahn, David J. Hunter, Susan E. Hankinson, David G. Cox, Per Hall, Sara Wedrén, Jianjun Liu, Yen-Ling Low, Natalia Bogdanova, Peter Schürmann, Thilo Dörk, Rob A.�E.�M. Tollenaar, Catharina E. Jacobi, Peter Devilee, Jan G.M. Klijn, Alice J. Sigurdson, Michele M. Doody, Bruce H. Alexander, Jinghui Zhang, Angela Cox, Ian W. Brock, Gordon R. Macpherson, Malcolm Reed, Fergus J. Couch, Ellen L. Goode, Janet E. Olson, Hanne Meijers‐Heijboer, Ans van den Ouweland, André G. Uitterlinden, Fernando Rivadeneira, Roger L. Milne, Gloría Ribas, Anna González‐Neira, Javier Benı́tez, John L. Hopper, Margaret McCredie, Melissa Southey, Graham G. Giles, Chris Schroen, Christina Justenhoven, Hiltrud Brauch
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Mary B. Daly, Tuya Pal, Michael P. Berry, Saundra S. Buys, Patricia Dickson, Susan M. Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L. Hutton, CGC, Beth Y. Karlan, Seema Khan, Catherine Klein, Wendy Kohlmann, CGC, Allison W. Kurian, Christine Laronga, Jennifer K. Litton, Julie Mak, LCGC, Carolyn S. Menendez, Sofía D. Merajver, Barbara S. Norquist, Kenneth Offit, Holly J. Pederson, Gwen Reiser, CGC, Leigha Senter-Jamieson, CGC, Kristen M. Shannon, Rebecca Shatsky, Kala Visvanathan, Jeffrey N. Weitzel, Myra Wick, Kari B. Wisinski, Matthew B. Yurgelun, Susan Darlow, Mary A. Dwyer
Where is BRCA gene mutations in cancer research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on BRCA gene mutations in cancer is open access?
ScholarIQopen access share
87%OPEN ACCESS